Suzanne Chamberland - Concepedia

Author

Suzanne Chamberland

Centre hospitalier de l'Université Laval

Also Known As

Chamberland, Suzanne, S Chamberland, S. CHAMBERLAND, S. Chamberland, SUZANNE CHAMBERLAND, Suzanne Chamberland

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Centre hospitalier de l'Université Laval Micron (United States)Essential Research (United States)University of Calgary Université de Sherbrooke

About

Suzanne Chamberland is an author at Centre hospitalier de l'Université Laval specializing in medicine, drug resistance, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	17	975
2	Health Sciences	10	10	635
3	Biochemistry	7	7	296
4	Natural Sciences	2	2	130
5	Engineering	1	1	20

Suzanne Chamberland

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in <i>Pseudomonas aeruginosa</i> : Novel Agents for Combination Therapy Olga Lomovskaya, Mark S. Warren, Angela Lee, Antimicrobial Agents and Chemotherapy	2001	877
Inhibitors of Efflux Pumps in <i>Pseudomonas </i><i>a</i><i>eruginosa</i> Potentiate the Activity of the Fluoroquinolone Antibacterial Levofloxacin Thomas E. Renau, Roger Léger, Eric M. Flamme, Journal of Medicinal Chemistry Mountain ViewAltmetric Attention ScoreAntimicrobial ChemotherapyAntibiotic ResistanceDrug Resistance	1999	254
Use of a Genetic Approach To Evaluate the Consequences of Inhibition of Efflux Pumps in <i>Pseudomonas aeruginosa</i> Olga Lomovskaya, Angela Lee, Kazuki Hoshino, Antimicrobial Agents and Chemotherapy	1999	216
Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa Thomas E. Renau, Roger Léger, L. K. FILONOVA, Bioorganic & Medicinal Chemistry Letters Efflux Pump InhibitorsAntimicrobial SusceptibilityAntibioticsMedicinePseudomonas Aeruginosa	2003	95
Peptidomimetics of Efflux Pump Inhibitors Potentiate the Activity of Levofloxacin in Pseudomonas aeruginosa Thomas E. Renau, Roger Léger, Rose Yen, Bioorganic & Medicinal Chemistry Letters Antimicrobial SusceptibilityHealth SciencesAntibioticsMedicineCombination Therapy	2002	80
The relationship between physicochemical properties, In vitro activity and pharmacokinetic profiles of analogues of diamine-Containing efflux pump inhibitors William J. Watkins, Yakira Landaverry, Roger Léger, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ScienceBiochemistryMedicineNatural Sciences	2003	79
Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis Suzanne Chamberland, Arnold S. Bayer, Tineke Schollaardt, Antimicrobial Agents and Chemotherapy Outer Membrane PermeabilityQuinolone ResistanceAntimicrobial ChemotherapyAntibiotic ResistanceDrug Resistance	1989	64
Antibiotic Susceptibility Profiles of 941 Gram-Negative Bacteria Isolated from Septicemic Patients Throughout Canada Suzanne Chamberland, J. L'Ecuyer, C Lessard, Clinical Infectious Diseases	1992	62
Addressing the stability of C-capped dipeptide efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa Thomas E. Renau, Roger Léger, Eric M. Flamme, Bioorganic & Medicinal Chemistry Letters Antimicrobial SusceptibilityHealth SciencesMedicineCombination TherapyPseudomonas Aeruginosa	2001	58
Comparative activity of macrolides against Toxoplasma gondii demonstrating utility of an in vitro microassay Suzanne Chamberland, Herbert A. Kirst, William L. Current Antimicrobial Agents and Chemotherapy Parasitic DiseaseAntiparasitic AgentImmunologyPathologyVitro Microassay	1991	53

Page 1